Zivo Bioscience Inc (ZIVO)

[Amigo Mike]

Damn .... took almost 2 weeks to put out a PR on the 8K. Sloppy. These guys really need to learn how to write things. Now you have negative perception ... twice ... instead of just once. Still not learning.

What do you want investors to take away from the PR ??? Debt ? Extension ? Conversion ? Do you really want to talk about technical defaults ???? Those usually have pretty negative connotations. OR DO YOU WANT INVESTORS TO KNOW WHY THIS IS A GOOD THING ????

Headline should read .......
ZIVO Bioscience expands line of credit with primary lender to support monetization of intellectual property for animal applications ... cause you didn't mention Wellmetris.

The only thing happened here was an increase of the limit and moving due dates on prior lent money. Everything else was already agreed too in January 2015 as stated. Money lent under the agreement is convertible at the current market price at the time the money is provided. We certainly would not want money lent at these prices AND ... the money may actually NEVER be lent (since another poster did not answer the question as to how much dilution this represents). So at the moment it is merely a pledge of more money.

Even trying to show the positive they don't get it .... you just got an increase in line of credit ...... talk about "more investment" ?? LOL.

The Company is moving forward on several fronts, including feed ingredient applications for dairy and beef cattle, performance supplement development, compliance initiatives for both animal and human uses, characterization and productizing efforts.

"Our key collaboration agreement is still in place and active, while we work toward other, similar arrangements," states Andrew A. Dahl, ZIVO president and chief executive officer. "We continue to expand our working relationships and develop production, extraction and finishing capabilities to make our licensing model that much more valuable."

Moving forward on several fronts is potentially an issue unless you JV them out. Split the cash on different streams .... end result ... need more money.

No mention of Wellmetris. Of course could have been purposeful given they have been asking for money for Wellmetris since day 1.

Got one thing right in PR ..... disproving the BS comments posted here. Zoetis is still in play. However err'd in not describing whether the money pledged will be used TO COMPLETE the collaboration ..... however for those paying attention it is known the collaboration requires the characterization of the bioactive which supports remaining efforts. "similar arrangements" take too long. Need deals with "different arrangements" where money or resources are attached that will get a vertical to the finish line .... and limit the potential for additional dilution.

Amigo Mike